Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Director/PDMR Shareholding

22 Dec 2025 07:00

RNS Number : 3505M
Diploma PLC
22 December 2025
 

10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EETELEPHONE: +44 (0)20 7549 5700

 

22 December 2025

 

Director/PDMR Shareholding and Long Term Incentive Award

 

Diploma PLC (the "Company") announces that on 19 December 2025, Wilson Ng, Chief Financial Officer, acquired a beneficial interest in 410 Ordinary Shares in the Company at £53.69 per share. Following this transaction, Wilson's total shareholding is 5,397 Ordinary Shares.

The shares were purchased using an amount equal to 50% of Wilson's annual bonus, net of tax, awarded for FY2025. These shares will be held under restriction in accordance with the Company's Shareholding Policy.The Company further announces that the Remuneration Committee has approved the grant of a long-term incentive award (the "Award") to Wilson on 19 December 2025 under the Diploma PLC 2020 Performance Share Plan (as amended) ("PSP"). A total of 12,289 Ordinary Shares were awarded at a share price of £53.40.

The Award is subject to the achievement of performance conditions measured over a three-year period ending 30 September 2028.The number of shares stated above represents the maximum that may vest in connection with this Award.

A summary of the PSP, including the performance conditions applicable to this Award, is provided in the Company's Annual Report and Accounts 2025.

The Notification of Dealing Form for both transactions can be found below. This announcement is made in accordance with the UK Market Abuse Regulation.

 

1

Details of the Director/PDMR/PCA

a)

Name

Wilson Ng

2

Reason for the notification

a)

Position/Status

Chief Financial Officer

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer

a)

Name

Diploma PLC

b)

LEI

2138008OGI7VYG8FGR19

4

Details of the transactions:

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 5p each in the Company

 

 

GB0001826634

b)

Nature of the transaction

1) Purchase of shares

2) Grant of PSP shares

c)

Price(s) and volume(s)

 

 

Price

Volume

1

Purchase at £53.69

410

2

Grant at £53.40

12,289

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

Price

Volume

1

Purchase at £53.69

410

2

Grant at £53.40

12,289

e)

Date of the transaction

19 December 2025

f)

Place of the transaction

1. London Stock Exchange

2. Outside a trading venue

 

For further information please contact:

Diploma PLC

Tel: +44 (0)20 7549 5700

Anna Lawrence, Group General Counsel & Company Secretary

 

LEI: 2138008OGI7VYG8FGR19

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZMMZKLNGKZM
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.